Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jens Lutz, Kerstin Jurk & Helmut Schinzel. (2017) Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations. International Journal of Nephrology and Renovascular Disease 10, pages 135-143.
Read now
Read now
Daniela Poli & Emilia Antonucci. (2015) Epidemiology, diagnosis, and management of atrial fibrillation in women. International Journal of Women's Health 7, pages 605-614.
Read now
Read now
Jannik Langtved Pallisgaard, Tommi Bo Lindhardt, Jonas Bjerring Olesen, Morten Lock Hansen, Nicholas Carlson & Gunnar Hilmar Gislason. (2015) Management and prognosis of atrial fibrillation in the diabetic patient. Expert Review of Cardiovascular Therapy 13:6, pages 643-651.
Read now
Read now
Piera Capranzano, Eligio Miccichè, Lucia D’Urso, Fiorella Privitera & Corrado Tamburino. (2013) Personalizing oral anticoagulant treatment in patients with atrial fibrillation. Expert Review of Cardiovascular Therapy 11:8, pages 959-973.
Read now
Read now
Articles from other publishers (35)
Mohammed Obeidat, Malcolm Burgess & Gregory Y.H. Lip. (2022) Atrial Fibrillation in Heart Failure. Cardiology Clinics 40:2, pages 245-258.
Crossref
Crossref
. (2022) Recommendations from the ICM-VTE: General. Journal of Bone and Joint Surgery 104:Suppl 1, pages 4-162.
Crossref
Crossref
Paul A. Heidenreich, N. A. Mark EstesIIIIII, Gregg C. FonarowCorrine Y. Jurgens, Michelle M. Kittleson, Joseph E. MarineDavid D. McManus & Robert L. McNamara. (2021) 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circulation: Cardiovascular Quality and Outcomes 14:1.
Crossref
Crossref
Paul A. Heidenreich, N. A. Mark EstesIIIIII, Gregg C. Fonarow, Corrine Y. Jurgens, Michelle M. Kittleson, Joseph E. Marine, David D. McManus & Robert L. McNamara. (2021) 2020 Update to the 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter. Journal of the American College of Cardiology 77:3, pages 326-341.
Crossref
Crossref
Alberto Genovesi-Ebert, Carlotta Sorini-Dini, Stefania Angela Di Fusco, Giuseppe Imperoli & Furio Colivicchi. (2020) Is the risk of stroke in permanent and paroxysmal atrial fibrillation really the same? Therein lies the dilemma. Journal of Cardiovascular Medicine 21:8, pages 540-546.
Crossref
Crossref
Mohammed Obeidat, Malcolm Burgess & Gregory Y.H. Lip. (2020) Atrial Fibrillation in Heart Failure. Heart Failure Clinics 16:1, pages 107-120.
Crossref
Crossref
Craig T. January, L. Samuel Wann, Hugh Calkins, Lin Y. Chen, Joaquin E. Cigarroa, Joseph C. ClevelandJr.Jr., Patrick T. Ellinor, Michael D. Ezekowitz, Michael E. Field, Karen L. Furie, Paul A. Heidenreich, Katherine T. Murray, Julie B. Shea, Cynthia M. Tracy & Clyde W. Yancy. (2019) 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Heart Rhythm 16:8, pages e66-e93.
Crossref
Crossref
Craig T. January, L. Samuel Wann, Hugh CalkinsLin Y. ChenJoaquin E. CigarroaJoseph C. ClevelandJrJrPatrick T. EllinorMichael D. EzekowitzMichael E. FieldKaren L. FuriePaul A. HeidenreichKatherine T. MurrayJulie B. SheaCynthia M. TracyClyde W. Yancy. (2019) 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation 140:2.
Crossref
Crossref
Craig T. January, L. Samuel Wann, Hugh Calkins, Lin Y. Chen, Joaquin E. Cigarroa, Joseph C. ClevelandJr.Jr., Patrick T. Ellinor, Michael D. Ezekowitz, Michael E. Field, Karen L. Furie, Paul A. Heidenreich, Katherine T. Murray, Julie B. Shea, Cynthia M. Tracy & Clyde W. Yancy. (2019) 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Journal of the American College of Cardiology 74:1, pages 104-132.
Crossref
Crossref
Lei Zhao, William Y. S. Wang & Xinchun Yang. (2018) Anticoagulation in atrial fibrillation with heart failure. Heart Failure Reviews 23:4, pages 563-571.
Crossref
Crossref
Roxana‐Nicoleta Siliste, Elena‐Laura Antohi, Sergey Pepoyan, Eleni Nakou & Panos Vardas. (2018) Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice. European Journal of Heart Failure 20:6, pages 978-988.
Crossref
Crossref
Arnaud Bisson, Denis Angoulvant, Raphael Philippart, Nicolas Clementy, Dominique Babuty & Laurent Fauchier. (2017) Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation. Advances in Therapy 34:6, pages 1283-1290.
Crossref
Crossref
Ayeesha Kamran Kamal, Adeel Khoja, Bushra Usmani, Abdul Muqeet, Fabiha Zaidi, Masood Ahmed, Saadia Shakeel, Nabila Soomro, Ambreen Gowani, Nargis Asad, Asma Ahmed, Saleem Sayani, Iqbal Azam & Sarah Saleem. (2016) Translating knowledge for action against stroke – using 5-minute videos for stroke survivors and caregivers to improve post-stroke outcomes: study protocol for a randomized controlled trial (Movies4Stroke). Trials 17:1.
Crossref
Crossref
Y Chugh & RT Faillace. (2016) The C of CHADS: Historical perspective and clinical applications for anticoagulation in patients with non valvular atrial fibrillation and congestive heart failure. International Journal of Cardiology 224, pages 431-436.
Crossref
Crossref
Matthew Carazo, Jeffrey S. Berger, Alex Reyentovich & Stuart D. Katz. (2016) Role of Antiplatelet Therapy and Anticoagulation in Nonischemic Cardiomyopathy. Cardiology in Review 24:5, pages 211-217.
Crossref
Crossref
Aatish Garg, Monica Khunger, Sinziana Seicean, Mina K. Chung & Patrick J. Tchou. (2016) Incidence of Thromboembolic Complications Within 30 Days of Electrical Cardioversion Performed Within 48 Hours of Atrial Fibrillation Onset. JACC: Clinical Electrophysiology 2:4, pages 487-494.
Crossref
Crossref
Paul A. Heidenreich, Penelope Solis, N. A. Mark EstesIIIIII, Gregg C. Fonarow, Corrine Y. Jurgens, Joseph E. Marine, David D. McManus & Robert L. McNamara. (2016) 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter. Journal of the American College of Cardiology 68:5, pages 525-568.
Crossref
Crossref
Paul A. Heidenreich, Penelope Solis, N. A. Mark EstesIIIIII, Gregg C. Fonarow, Corrine Y. Jurgens, Joseph E. Marine, David D. McManus & Robert L. McNamara. (2016) 2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter. Circulation: Cardiovascular Quality and Outcomes 9:4, pages 443-488.
Crossref
Crossref
Oliver J. Ziff & A. John Camm. (2016) Individualized approaches to thromboprophylaxis in atrial fibrillation. American Heart Journal 173, pages 143-158.
Crossref
Crossref
Qinmei Xiong, Yee Cheng Lau, Keitaro Senoo, Deirdre A. Lane, Kui Hong & Gregory Y.H. Lip. (2015) Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials. European Journal of Heart Failure 17:11, pages 1192-1200.
Crossref
Crossref
Duy Duc An Bui, Siddhartha Jonnalagadda & Guilherme Del Fiol. (2015) Automatically finding relevant citations for clinical guideline development. Journal of Biomedical Informatics 57, pages 436-445.
Crossref
Crossref
Michela Brambatti, Harald Darius, Jonas Oldgren, Andreas Clemens, Herbert H. Noack, Martina Brueckmann, Salim Yusuf, Lars Wallentin, Michael D. Ezekowitz, Stuart J. Connolly & Jeff S. Healey. (2015) Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial. International Journal of Cardiology 196, pages 127-131.
Crossref
Crossref
Renato De Vecchis, Cesare Baldi & Francesco Piemonte. (2015) Comparative Analysis of the Effects of Three Antithrombotic Regimens on Clinical Outcomes of Patients with Atrial Fibrillation and Recent Percutaneous Coronary Intervention with Stent. A Retrospective Cohort Study. International Journal of Statistics in Medical Research 4:3, pages 260-269.
Crossref
Crossref
C. T. January, L. S. Wann, J. S. Alpert, H. Calkins, J. E. Cigarroa, J. C. Cleveland, J. B. Conti, P. T. Ellinor, M. D. Ezekowitz, M. E. Field, K. T. Murray, R. L. Sacco, W. G. Stevenson, P. J. Tchou, C. M. Tracy & C. W. Yancy. (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 130:23, pages e199-e267.
Crossref
Crossref
C. T. January, L. S. Wann, J. S. Alpert, H. Calkins, J. E. Cigarroa, J. C. Cleveland, J. B. Conti, P. T. Ellinor, M. D. Ezekowitz, M. E. Field, K. T. Murray, R. L. Sacco, W. G. Stevenson, P. J. Tchou, C. M. Tracy & C. W. Yancy. (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 130:23, pages 2071-2104.
Crossref
Crossref
A. J. Wagstaff, T. F. Overvad, G. Y. H. Lip & D. A. Lane. (2014) Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis. QJM 107:12, pages 955-967.
Crossref
Crossref
Craig T. January, L. Samuel Wann, Joseph S. Alpert, Hugh Calkins, Joaquin E. Cigarroa, Joseph C. ClevelandJr.Jr., Jamie B. Conti, Patrick T. Ellinor, Michael D. Ezekowitz, Michael E. Field, Katherine T. Murray, Ralph L. Sacco, William G. Stevenson, Patrick J. Tchou, Cynthia M. Tracy & Clyde W. Yancy. (2014) 2014 AHA/ACC/HRS Guideline for?the?Management of Patients With?Atrial Fibrillation. Journal of the American College of Cardiology 64:21, pages e1-e76.
Crossref
Crossref
Craig T. January, L. Samuel Wann, Joseph S. Alpert, Hugh Calkins, Joaquin E. Cigarroa, Joseph C. ClevelandJr.Jr., Jamie B. Conti, Patrick T. Ellinor, Michael D. Ezekowitz, Michael E. Field, Katherine T. Murray, Ralph L. Sacco, William G. Stevenson, Patrick J. Tchou, Cynthia M. Tracy & Clyde W. Yancy. (2014) 2014 AHA/ACC/HRS Guideline for the?Management of Patients With Atrial Fibrillation: Executive Summary. Journal of the American College of Cardiology 64:21, pages 2246-2280.
Crossref
Crossref
Megha Agarwal, Stavros Apostolakis, Deirdre A. Lane & Gregory Y.H. Lip. (2014) The Impact of Heart Failure and Left Ventricular Dysfunction in Predicting Stroke, Thromboembolism, and Mortality in Atrial Fibrillation Patients: A Systematic Review. Clinical Therapeutics 36:9, pages 1135-1144.
Crossref
Crossref
Carlos J. Gonzalez-Quesada & Robert P. Giugliano. (2014) Comparison of the Phase III Clinical Trial Designs of Novel Oral Anticoagulants Versus Warfarin for the Treatment of Nonvalvular Atrial Fibrillation: Implications for Clinical Practice. American Journal of Cardiovascular Drugs 14:2, pages 111-127.
Crossref
Crossref
Paul A. Gurbel & Udaya S. Tantry. (2014) Antiplatelet and Anticoagulant Agents in Heart Failure. JACC: Heart Failure 2:1, pages 1-14.
Crossref
Crossref
Isabelle C. Van Gelder, Dirk J. Van Veldhuisen & Gregory Y.H. Lip. (2014) New oral anticoagulants in heart failure. European Journal of Heart Failure 15:9, pages 966-973.
Crossref
Crossref
Jorge Ferreira, Michael D. Ezekowitz, Stuart J. Connolly, Martina Brueckmann, Mandy Fraessdorf, Paul A. Reilly, Salim Yusuf & Lars Wallentin. (2014) Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE‐LY trial. European Journal of Heart Failure 15:9, pages 1053-1061.
Crossref
Crossref
Sean van DiepenAnne S. HellkampManesh R. PatelRichard C. BeckerGünter BreithardtWerner HackeJonathan L. HalperinGraeme J. HankeyChristopher C. NesselDaniel E. SingerScott D. BerkowitzRobert M. CaliffKeith A.A. FoxKenneth W. Mahaffey. (2013) Efficacy and Safety of Rivaroxaban in Patients With Heart Failure and Nonvalvular Atrial Fibrillation. Circulation: Heart Failure 6:4, pages 740-747.
Crossref
Crossref
Ron Pisters & Gregory Y. H. Lip. (2012) Safety and Efficacy of New Anticoagulants in Patients with Heart Failure. Current Heart Failure Reports 10:1, pages 18-25.
Crossref
Crossref